Large-scale EU FP7 NMP funded
R&D Project March 2013 - March 2018
CosmoPHOS-nano is a multidisciplinary translational and business-oriented project aiming to develop and evaluate in both nonclinical and clinical applications a novel theranostic (diagnostic & therapeutic) nanotechnology-enabled portable combination system which will enable:
The CosmoPHOS System is anticipated to reduce
the number of deaths and morbidity caused by CAD by up to 40%, which we forecast to result in
a significant decrease in European and global healthcare costs caused
by CAD, increase the income of the European healthcare industry
from the CAD market, which is the global largest, and alleviate the European
and Global Society.
The CosmoPHOS-nano Project is the world's largest R&D Project of Nanomedicine in Cardiology, consisting of 19 world-class Participants including 13 Universities and Research Foundations and 6 Companies. These academic and industrial partners have spent more than nine years successfully collaborating, and the CosmoPHOS-nano project marks a significant milestone in the Consortium's ongoing efforts to combat the devastating effect of CAD on European and global societies.